Bicycle Therapeutics Plc (BCYC)
4.34
-0.03
(-0.69%)
USD |
NASDAQ |
Aug 24, 16:00
4.42
+0.08
(+1.84%)
After-Hours: 20:00
Bicycle Therapeutics Total Liabilities (Quarterly) : 96.32M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 96.32M |
| March 31, 2026 | 98.08M |
| December 31, 2025 | 107.62M |
| September 30, 2025 | 145.48M |
| June 30, 2025 | 163.27M |
| March 31, 2025 | 143.56M |
| December 31, 2024 | 163.81M |
| September 30, 2024 | 165.71M |
| June 30, 2024 | 183.54M |
| March 31, 2024 | 191.10M |
| December 31, 2023 | 224.41M |
| September 30, 2023 | 222.66M |
| June 30, 2023 | 234.07M |
| March 31, 2023 | 185.64M |
| December 31, 2022 | 139.83M |
| September 30, 2022 | 127.67M |
| June 30, 2022 | 134.09M |
| March 31, 2022 | 129.30M |
| Date | Value |
|---|---|
| December 31, 2021 | 133.54M |
| September 30, 2021 | 110.51M |
| June 30, 2021 | 84.00M |
| March 31, 2021 | 81.75M |
| December 31, 2020 | 65.69M |
| September 30, 2020 | 60.51M |
| June 30, 2020 | 47.58M |
| March 31, 2020 | 47.47M |
| December 31, 2019 | 17.00M |
| September 30, 2019 | 20.74M |
| June 30, 2019 | 21.69M |
| March 31, 2019 | 28.99M |
| December 31, 2018 | 29.26M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 30.83M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Autolus Therapeutics Plc | 418.39M |
| Akari Therapeutics Plc | 20.03M |
| Biodexa Pharmaceuticals Plc | -- |
| DBV Technologies SA | 62.80M |
| Cellectis SA | 226.30M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 606.58M |
| Shareholders Equity (Quarterly) | 510.26M |
| Debt to Equity Ratio | 0.0298 |
| Current Ratio | 12.08 |
| Net Debt Paydown Yield | -0.57% |